BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35501515)

  • 1. Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
    Lugtenberg RT; van den Hurk CJG; Smorenburg CH; Mosch L; Houtsma D; Deursen MAGDH; Kaptein AA; Gelderblom H; Kroep JR
    Support Care Cancer; 2022 Aug; 30(8):6641-6648. PubMed ID: 35501515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
    Komen MM; Breed WP; Smorenburg CH; van der Ploeg T; Goey SH; van der Hoeven JJ; Nortier JW; van den Hurk CJ
    Support Care Cancer; 2016 Jun; 24(6):2735-41. PubMed ID: 26805558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
    Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.
    Heibloem RE; Komen MMC; Ilozumba OUC; van den Hurk CJG
    Support Care Cancer; 2023 Apr; 31(5):273. PubMed ID: 37067605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
    van den Hurk CJ; Breed WP; Nortier JW
    Support Care Cancer; 2012 Dec; 20(12):3255-60. PubMed ID: 22539051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.
    Betticher DC; Delmore G; Breitenstein U; Anchisi S; Zimmerli-Schwab B; Müller A; von Moos R; Hügli-Dayer AM; Schefer H; Bodenmann S; Bühler V; Trueb RR
    Support Care Cancer; 2013 Sep; 21(9):2565-73. PubMed ID: 23636645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
    Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
    Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.
    Macduff C; Mackenzie T; Hutcheon A; Melville L; Archibald H
    Eur J Cancer Care (Engl); 2003 Jun; 12(2):154-61. PubMed ID: 12787013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: a randomized pilot study.
    Carton E; Blas AM; Perret C; Le Bihan M
    Support Care Cancer; 2024 Jun; 32(7):410. PubMed ID: 38839667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
    Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
    Rice BA; Ver Hoeve ES; DeLuca AN; Esserman LJ; Rugo HS; Melisko ME
    Breast Cancer Res Treat; 2018 Jan; 167(1):117-122. PubMed ID: 28921303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
    van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
    Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
    Vasconcelos I; Wiesske A; Schoenegg W
    Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
    Carbognin L; Accetta C; Di Giorgio D; Fuso P; Muratore M; Tiberi G; Pavese F; D'Angelo T; Fabi A; Giannarelli D; Di Leone A; Magno S; Garganese G; Sanchez AM; Terribile DA; Franceschini G; Masetti R; Scambia G; Paris I
    Curr Oncol; 2022 Sep; 29(10):7218-7228. PubMed ID: 36290846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia.
    Orlando L; Loparco D; Fedele P; Schiavone P; Quaranta A; Caliolo C; Cinefra M; Rizzo P; Calvani N; Morleo A; Varriano R; Bonuso V; Falcone LL; Caloro M; Cinieri S
    Future Oncol; 2019 Oct; 15(29):3337-3344. PubMed ID: 31578891
    [No Abstract]   [Full Text] [Related]  

  • 19. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
    Ohsumi S; Kiyoto S; Takahashi M; Hara F; Takashima S; Aogi K; Matsuda M; Yamamura N; Doi M
    Support Care Cancer; 2021 Jan; 29(1):437-443. PubMed ID: 32388615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
    Dilawari A; Gallagher C; Alintah P; Chitalia A; Tiwari S; Paxman R; Adams-Campbell L; Dash C
    Oncologist; 2021 Apr; 26(4):292-e548. PubMed ID: 33512741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.